Cargando…
Diabetes outcomes before and during telehealth advancements surrounding COVID-19
BACKGROUND: Pharmacists can optimize outcomes related to type-2 diabetes (T2D) by taking advantage of telehealth opportunities despite the coronavirus 2019 (COVID-19) Public Health Emergency (PHE). OBJECTIVE: Identify and compare changes in T2D outcomes before (August 2019 through February 2020) and...
Autores principales: | Woodhouse, Ashley G., Orvin, Chelsea, Rich, Caleb, Crosby, Joseph, Keedy, Chelsea A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Pharmacists Association®. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479448/ https://www.ncbi.nlm.nih.gov/pubmed/34635442 http://dx.doi.org/10.1016/j.japh.2021.09.011 |
Ejemplares similares
-
Meeting the needs of rural veterans through rapid implementation of pharmacist-provided telehealth management of diabetes during the COVID-19 pandemic
por: Baum, Shekinah G., et al.
Publicado: (2023) -
Impact of regulatory changes on pharmacist-delivered telehealth during the COVID-19 pandemic
por: Pritchard, Roger Iain, et al.
Publicado: (2020) -
Virtual medication tours with a pharmacist as part of a cystic fibrosis telehealth visit
por: Warda, Nicole, et al.
Publicado: (2021) -
Addressing the need for a telehealth readiness assessment tool as a digital health strategy
por: Bingham, Jennifer M., et al.
Publicado: (2022) -
Telehealth use in Australian primary healthcare during COVID-19: a cross-sectional descriptive survey
por: Halcomb, Elizabeth J, et al.
Publicado: (2023)